Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0039 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.0006 | 0.0006 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.4828 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0039 | 0 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0006 | 0.5 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0099 | 0.4828 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.5 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.4828 |
Echinococcus multilocularis | serotonin receptor | 0.0164 | 1 | 1 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0099 | 0.4828 | 0.5 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.0099 | 0.4828 | 0.5 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0099 | 0.4828 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0006 | 0.5 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.4828 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0099 | 0.4828 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.0006 | 0.0006 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.5 |
Leishmania major | farnesyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0006 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0099 | 0.4828 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 1 | 1 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.0099 | 0.4828 | 0.5 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0099 | 0.4828 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 1 | 1 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.0006 | 0.5 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.0099 | 0.4828 | 0.5 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0099 | 0.4828 | 0.4828 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0099 | 0.4828 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0164 | 1 | 1 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.0006 | 0.0006 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.0006 | 0.0006 |
Onchocerca volvulus | 0.0039 | 0 | 0.5 | |
Brugia malayi | hypothetical protein | 0.004 | 0.0006 | 0.0013 |
Echinococcus multilocularis | serotonin receptor | 0.0164 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.